Beginning Jan. 26, veterinarians for the New York Racing Association (NYRA) will administer Lasix (a drug given to racehorses to lessen the severity of exercise-induced pulmonary hemorrhage) to horses on race day.

"This important integrity measure will eliminate the need for private veterinarians to enter horses' stalls on race days," NYRA president and CEO Charles Hayward said. "Combined with the expanded in-house drug testing program that was instituted last summer, we are very pleased with the progress made to protect the integrity of NYRA racing."

Beginning with last year's meet at Saratoga, NYRA enhanced its in-house drug testing program to detect illegal performance-enhancing substances in Thoroughbred race horses utilizing state-of-the-art science, technology, and procedural processes. The program includes random out-of-competition testing designed to effectively deter the use of blood-doping agents such as erythropoietin (EPO), bronchial dilators, and other emerging threats.

At that time, NYRA also ceased operations of the security barn, initiating an "in-today" process that identifies all horses, in their stalls, running in a NYRA race within 24 hours. NYRA tests illegal levels of total carbon dioxide (TCO2, known as "milkshaking") through an assembly barn where all horses entering a race are required to report just prior to moving to the paddock for saddling.

NYRA is the only racing circuit where private veterinarians do not administer Lasix.

Originally posted on

About the Author

The Blood-Horse Staff

The Blood-Horse is the leading weekly publication devoted to international Thoroughbred racing and breeding. Since 1916, the staff of The Blood-Horse has served the Thoroughbred community with the highest standards of journalistic excellence to provide comprehensive and timely editorial coverage and analysis.

Stay on top of the most recent Horse Health news with FREE weekly newsletters from Learn More